I am a
Home I AM A Search Login

Papers of the Week

Papers: 7 Mar 2020 - 13 Mar 2020

2020 Feb 11

Hum Gene Ther

Viral Vector-Mediated Gene Transfer of Glutamic Acid Decarboxylase for Chronic Pain Treatment: A Literature Review.


Kanao-Kanda M, Kanda H, Liu S, Roy S, Toborek M, Hao S
Hum Gene Ther. 2020 Feb 11.
PMID: 32041431.


Chronic pain is long-lasting nociceptive state, impairing the patient's quality of life. Existing analgesics are generally not effective in the treatment of chronic pain, some of which such as opioids have the risk of tolerance/dependence, overdose death with higher daily opioid doses for increasing analgesic effect. Opioid use disorders have already reached an epidemic level in the United States, therefore, non-opioid analgesic approach and/or use of non-pharmacologic interventions will be employed with increasing frequency. Viral vector mediated gene therapy is promising in clinical trials in the nervous system diseases. Glutamic acid decarboxylase (GAD) enzyme, a key enzyme in biosynthesis of GABA, plays an important role in analgesic mechanism. In the literature review, we used PubMed and BioRxiv to search the studies, and the eligible criteria include (1) manuscript written in English, (2) use of viral vectors expressing GAD67 or GAD65, and (3) preclinical pain models. We identified 13 eligible original research papers, in which the pain models include nerve injury, HIV-related pain, painful diabetic neuropathy, and formalin test. GAD expressed by the viral vectors from all of the reports produced antinociceptive effects. Restoring GABA systems is a promising therapeutic strategy for chronic pain, which provides evidence for the clinical trial of gene therapy for pain in the near future.